Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | GBA1 | P04062 | 1/20 | 0.34 |
| ▸ | ACE | P12821 | 3/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.33 |
| ▸ | FDPS | P14324 | 3/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | PRKCD | Q05655 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24376718 | 0.70 | DUSP3 (0.42) | PTPN1GPR84FDPSFFAR1 | |
| SCHEMBL24376277 | 0.70 | PSEN1 (0.35) | LMNAGPR84FDPSFFAR1 | |
| SCHEMBL7481386 | 0.62 | DUSP3 (0.38) | PTPN1 | |
| SCHEMBL24450057 | 0.61 | CA2 (0.39) | LMNAGPR84FDPSFFAR1 | |
| SCHEMBL29004050 | 0.61 | TRPA1 (0.38) | PTPN1GBA1ACEGPR84FDPS | |
| SCHEMBL23545051 | 0.61 | CA2 (0.39) | LMNAGPR84FDPSFFAR1 | |
| SCHEMBL23509686 | 0.59 | RGS4 (0.44) | PTPN1LMNASMN1; SMN2HTTALDH1A1 | |
| SCHEMBL4062741 | 0.57 | TSHR (0.57) | LMNAGPR84FDPSFFAR1 | |
| SCHEMBL634579 | 0.57 | TSHR (0.57) | LMNAGPR84FDPSFFAR1 | |
| SCHEMBL14533500 | 0.57 | TSHR (0.57) | LMNAGPR84FDPSFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220127255-A1 | HERBICIDAL COMPOUNDS | SYNGENTA CROP PROTECTION AG (GB) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127255-A1 | HERBICIDAL COMPOUNDS | DDT, HDHD5, HPD | PTPN1 440/4885LMNA 4081/4885SMN1; SMN2 4663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.